PLA2G1B
MOLECULAR TARGETphospholipase A2 group IB
PLA2G1B (phospholipase A2 group IB) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PLA2G1B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | taurursodiol | 3.30 | 26 |
| 2 | manoalide | 2.77 | 15 |
| 3 | varespladib | 2.48 | 11 |
| 4 | abyssinone v | 2.08 | 7 |
| 5 | Quercetin | 0.69 | 1 |
| 6 | Chenodeoxycholic Acid | 0.69 | 1 |
| 7 | Cholic Acid | 0.69 | 1 |
| 8 | Hexachlorophene | 0.69 | 1 |
| 9 | Oleanolic Acid | 0.69 | 1 |
| 10 | Taurodeoxycholic Acid | 0.69 | 1 |
About PLA2G1B as a Drug Target
PLA2G1B (phospholipase A2 group IB) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented PLA2G1B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PLA2G1B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.